Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
-
$4 Million Gift Helps Create New Center for Inflammatory Bowel Disease at NewYork-Presbyterian/Weill Cornell
-
Adolescent Girl Athletes More Likely to Injure Knees Than Boys
-
Americans Encouraged to Make Many Lifestyle Changes, Not Just One, to Reduce Cardiovascular Risk
-
A Shot in the Arm Could Save Your Child's Life
-
Avon Foundation Breast Imaging Center and Research Lab Open at NewYork-Presbyterian Hospital and Columbia University Medical Center
-
Breathe Easier! Family Guide to Winter Allergies
-
Common Sense and Care: Tips for Holiday Fire Prevention
-
Comprehensive Care for Complex, High-Risk Pregnancies
-
Comprehensive Review Finds Job Stress Does Not Contribute to Chronic High Blood Pressure
-
Contrary to Popular Wisdom, Expressing Anger Is Not Healthy
-
Diabetics Benefit Less from Anti-Hypertensive Treatment to Reduce Enlarged Heart
-
DNA Analysis Could Boost Accuracy of Thyroid Tests, NewYork-Presbyterian/Weill Cornell Team Reports
-
Dr. Jack Barchas Receives Institute of Medicine's 2006 Sarnat Award in Mental Health
-
Dr. Joseph Tenenbaum Named New Chief of Medicine Division at NewYork-Presbyterian Hospital/The Allen Pavilion
-
Dr. Laura Forese, Chief Medical Officer, Appointed Chief Operating Officer of NewYork-Presbyterian/Weill Cornell
-
Dr. Richard Polin Receives Education Award from the American Academy of Pediatrics
-
Dr. Scott Hammer Authors Two New Guidelines for HIV Treatment
-
Electrocardiogram Helps Predict Risk for Congestive Heart Failure in Hypertensive Patients
-
Female Smokers Face Double the Risk for Lung Cancer Compared to Male Smokers, NewYork-Presbyterian/Weill Cornell Study Finds
-
For High Blood Pressure Patients, Preventing or Reducing Enlarged Heart Decreases Risk of Deadly Atrial Fibrillation
-
Four-Drug Combo Is No Improvement Over Standard Three-Drug Regimen in Suppressing HIV, NewYork-Presbyterian/Weill Cornell-Led Study Finds
-
Fritz Reuter Appointed SVP for Facilities Development and Real Estate at NewYork-Presbyterian
-
From Ancient Egypt to the Science Lab to Your Dinner Plate... Garlic: It's Good for You!
-
Greenberg Prize Awarded to Dr. Isadore Rosenfeld
-
Halloween Horror Movies May Cause Emotional Problems in Young Children
-
How to Avoid Holiday and Winter Weight Gain
-
Improved Treatment for Infants with Misshapen Heads
-
Integrative Therapies Program for Children with Cancer at Morgan Stanley Children's Hospital of NewYork-Presbyterian Receives Gift Commitment from Origins Natural Resources
-
IVIG Antibodies Provide Lasting Benefits to Alzheimer's Patients, According to NewYork-Presbyterian/Weill Cornell Study
-
Keeping the Beat: NewYork-Presbyterian Offers Heart Patients New Combination Defibrillator/Pacemakers
-
Landmark Study Reveals That Lung Cancer 10-Year Survival Dramatically Improves With Annual CT Screening and Prompt Treatmen
-
Larger Waistline Is Linked to Increased Risk for Heart Disease in Women
-
Largest U.S. Hepatitis C Trial Provides Insight Into Optimizing Treatment for Patients
-
Latest Findings Presented at Second International Symposium on Pediatric Non-Hodgkin's Lymphoma
-
Learning from 9/11: NewYork-Presbyterian/Weill Cornell Study Reviews Hospital's Disaster Preparedness
-
Lending a Helping Hand: New Device for Stroke Patients Restores Hand Mobility
-
Local Pediatric Patient Heads to Capitol Hill Today in Hopes of Preserving Children's Hospital Funding
-
Merry Stressmas
-
Morgan Stanley Children's Hospital Appoints Emergency Medicine Doctors
-
Most Children with First Complex Febrile Seizures Unlikely to Need Emergency Neuroimaging
-
Multiple Myeloma Oral Therapy REVLIMID Approved by FDA
-
New Alternative to Hip Replacement
-
New Columbia University Division of Geriatric Medicine and Aging to Open at NewYork-Presbyterian/The Allen Pavilion
-
New Procedure Offers Hope to Patients at High Risk for Recurrent Stroke
-
New Radiation Therapy for Prostate Cancer Has Fewer Side Effects
-
New Studies Offer Virtual Reality Therapy for Psychological Victims of Sept. 11
-
NewYork-Presbyterian/Columbia Announces State-of-the-Art, Vivian and Seymour Milstein Family Heart Center in Washington Heights
-
NewYork-Presbyterian/Columbia Physician has Developed a Potential Nonsurgical Alternative to Mitral Valve Surgery
-
NewYork-Presbyterian/Columbia Sets U.S. Record for Number of Heart Transplants in One Year
-
NewYork-Presbyterian/Columbia Trains Surgeons in New Alternative to Hip Replacement
-
NewYork-Presbyterian/Weill Cornell Names Dr. Nitsana Spigland Chief of Pediatric Surgery
-
NewYork-Presbyterian/Weill Cornell Physicians are the First to Test Gene Therapy as a Potential Treatment for Parkinson's Disease
-
NewYork-Presbyterian's Back-To-School Health Checklist
-
NewYork-Presbyterian Launches Awareness Campaign for Interpreter Services Program
-
NewYork-Presbyterian Names Dr. Robert Grant Chief of Plastic and Reconstructive Surgery
-
NewYork-Presbyterian Ranks #1 in New York Magazine's Best Hospitals Survey
-
NewYork-Presbyterian Ranks 6th in Nation in 2006 U.S. News & World Report "Best Hospitals"
-
NewYork-Presbyterian Receives Highest Accreditation for Bariatric Surgery
-
NewYork-Presbyterian Receives NY State Stroke Center Designation
-
No Tricks – Just Treats!
-
Novel Drug Boosts Platelet Production, Reversing Chronic Immune Thrombocytopenic Purpura (ITP)
-
Nurses Name Physicians of the Year at NewYork-Presbyterian/Weill Cornell
-
NYC's First 3-Way Kidney Transplant
-
NYC Conference on Medical Interpreting and Culturally Competent Health Care
-
NYC First: NewYork-Presbyterian/Columbia Cardiologists Implant Novel Stroke-Prevention Device for Heart Patients with Atrial Fibrillation
-
Parents Happier with Alternative to Liquid Meds for Tonsillectomy
-
Researcher Predicts Paradigm Shift in Heart Disease Treatment
-
Responding to Obesity Epidemic, New Adolescent Bariatric Surgery Center Opens at Morgan Stanley Children's Hospital of NewYork-Presbyterian
-
Review Outlines Risks and Benefits of Body Contouring for Massive Weight Loss After Bariatric Surgery
-
Smokers and Former Smokers Should Be Screened for Lung Cancer, Even If They do not Have Symptoms
-
Surgery Simulators Effective at Training Surgeons
-
Take Me to Chicago!
-
The Facts and Fictions About Flu and Colds
-
The Seventh Issue of Cancer Prevention Has Arrived!
-
Tired of Scratching?
-
Two-Drug Therapy Could Become New Standard of Care for Moderate-to-Severe Male Overactive Bladder
-
U.S. Dept. of Health and Human Services Commends Mental Health Program at NewYork-Presbyterian
-
Winter Exercise Warning
-
Winter Watch for Senior Citizens: 10 Tips for Having a Safe Season
Cardiovascular disease (CVD), or disease of the heart and blood vessels, continues to be a leading killer of men and women in the United States, accounting for close to 30 percent of all deaths annually. According to a leading researcher, CVD will remain a major cause of death unless Americans make a concerted effort to manage all of their risks.
"It's going to take a lot more than one small lifestyle change to reduce the toll of cardiovascular disease significantly," said Antonio M. Gotto Jr., MD, DPhil, dean and professor of medicine at the Weill Medical College of Cornell University in New York. "Although patients can't control their age, race and genetics, they can make positive changes that will affect their blood pressure, cholesterol levels, risk for diabetes, and weight, all of which contribute to cardiovascular disease."
Dr. Gotto spoke today at an American Medical Association media briefing, Cardiovascular Disease, in New York City.
Redefining Risk
The risks patients must consider and manage today differ substantially from the risks their parents and grandparents had to consider, said Dr. Gotto. At one time, cigarette smoking was a common practice and people were not as conscious of diet and exercise.
"Over the last 20 years, even the defining levels of cardiovascular risk factors have changed," explained Dr. Gotto. "We used to believe that an LDL, or bad cholesterol, level over 160 was too high, then it changed to 130 and then 100, as more clinical evidence became available. Now, based on the data, patients at very high risk for disease may need to keep their LDL under 70."
The same is true for high blood pressure. An "optimal" level was once considered less than 120/80 mm Hg. Now that same goal is considered "normal." A systolic blood pressure in the range of 120-140 mm Hg is now considered "pre-hypertension," a warning of blood pressure issues to come.
And the worldwide challenge of cardiovascular diseases is only likely to grow in the future. "As changes occur in the developing world, we're faced with an entirely new set of issues to combat in relation to cardiovascular disease, such as obesity and diabetes," Dr. Gotto added.
Management of all Risks
"The more risk factors someone has, the more likely he or she is to have cardiovascular disease," explained Dr. Gotto. "Having multiple risk factors exponentially increases your risk for having a heart attack or stroke. In cases where patients have two or more risk factors, the heart disease risk caused by the whole package is much worse than the risk associated with each individual risk factor."
In essence, this theory can also apply to prevention and management of risk factors; the more risk factors managed, the greater chance a patient can prevent heart disease.
"Research into risk has been extremely beneficial in giving physicians a better understanding of how they can help their patients," said Dr. Gotto. "The Diabetes Prevention Program demonstrated that several lifestyle changes, such as diet and exercise, can help prevent diabetes. But other studies, such as the Women's Health Initiative, suggest that making only one change, in this case a low-fat diet, isn't enough."
"Diet and exercise will only be effective if people also lower their blood pressure and cholesterol," he said. "Without management of all the issues related to one's cardiovascular health, it is very unlikely patients will reduce risk substantially and prevent disease."
Editor's Note: Dr. Gotto serves as a consultant for AstraZeneca Pharmaceuticals, Bristol Myers Squibb, Johnson & Johnson Merck, KOS Pharmaceuticals, KOWA, Merck, Merck/Schering-Plough, Novartis, Pfizer, and Reliant. He sits on the Board of Directors for Medtronic. Dr. Gotto has received an honorarium from the American Medical Association to speak at today's conference.